Page 84 - Molecular features of low-grade developmental brain tumours

3
82
CHAPTER 3
of Experimental Medicine and Medical Oncology, Brigham and Women’s Hospital, Boston,
USA) for performing TSC1/TSC2 mutation analysis.
Funding
This work was supported by KIKA (Stichting Kinderen Kankervrij; AB, AM, AS, BS, EA); Stichting AMC Foundation (EA); Stichting TSC Fonds (EA); the Austrian Science Fund (FWF, no. J3499; AM); the European Union 7th framework program: acronym EPISTOP (grant agreement no. 602391; FJ, VG, TS, MF, SJ, AM, JM, EA) and acronym DESIRE (grant agreement no. 602531; IB); the Polish Ministerial funds for science (years 2013-2018) for the implementation of international co-financed project (KK, SJ) and internal research project of the Children’s Memorial Health Institute no.S132/2013 (KK, SJ).
Conflict of Interest
The authors have no duality or conflicts of interest to declare.